Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability

MLA

Fassler, A., et al. “Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability.” Journal of Medicinal Chemistry, vol. 39, no. 16, Aug. 1996, pp. 3203–16. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs1108796&authtype=sso&custid=ns315887.

APA

Fassler, A., Bold, G., Capraro, H.-G., Cozens, R., Mestan, J., Poncioni, B., Rosel, J., Tintelnot-Blomley, M., & Lang, M. (1996). Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability. Journal of Medicinal Chemistry, 39(16), 3203–3216.

Chicago

Fassler, A., G. Bold, H.-G. Capraro, R. Cozens, J. Mestan, B. Poncioni, J. Rosel, M. Tintelnot-Blomley, and M. Lang. 1996. “Aza-Peptide Analogs as Potent Human Immunodeficiency Virus Type-1 Protease Inhibitors with Oral Bioavailability.” Journal of Medicinal Chemistry 39 (16): 3203–16. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=ejs1108796&authtype=sso&custid=ns315887.